Peer Navigator Training for HIV Prevention in Hispanic/Latino Men

N/A

Waitlist Available

Led By Scott D Rhodes, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be ≥18 years of age

Report identifying as male and having had sex with at least 1 man in the past 6 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to post-intervention up to 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to reduce HIV infection in Hispanic/Latino men who have sex with men. We must address disparities among vulnerable groups.

Who is the study for?

This trial is for Hispanic/Latino men, aged 18 or older, living in Mecklenburg County, NC who identify as gay or bisexual and have had sex with a man in the past 6 months. Participants must speak English and Spanish and provide informed consent.

What is being tested?

The study tests whether training peer navigators can help reduce HIV disparities among Hispanic/Latino men who have sex with men. Some participants will receive this intervention later to compare outcomes.

What are the potential side effects?

Since the intervention involves training rather than medication, traditional physical side effects are not expected; however, there may be emotional or social impacts from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am a man who has had sexual relations with another man in the last 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to post-intervention up to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to post-intervention up to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-intervention up to 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Rate of Human Immunodeficiency Virus (HIV) testing

Change in Rate of medical mistrust

Change in Rate of pre-exposure prophylaxis (PrEP) uptake

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: delayed-intervention groupExperimental Treatment1 Intervention

Training is designed to increase knowledge and skills. The delayed-intervention group will be trained in year 5

Group II: Navigators (peer navigator) trainingExperimental Treatment1 Intervention

Training is designed to increase knowledge and skills. Navigators in the intervention group will be trained and supported for 12 months of implementation across years 3 and 4

0 / 2Eligibility criteria met